<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>CRAN - Package remss</title>
<link rel="stylesheet" type="text/css" href="../../CRAN_web.css" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="citation_title" content="Refining Evaluation Methodology on Stage System [R package remss version 1.0.0]" />
<meta name="citation_author1" content="Wei Xu" />
<meta name="citation_author2" content="Susie Su" />
<meta name="citation_publication_date" content="2019-11-20" />
<meta name="citation_public_url" content="https://CRAN.R-project.org/package=remss" />
<meta name="DC.identifier" content="https://CRAN.R-project.org/package=remss" />
<meta name="DC.publisher" content="Comprehensive R Archive Network (CRAN)" />
<meta name="og:title" content="remss: Refining Evaluation Methodology on Stage System" />
<meta name="og:description" content="T (extent of the primary tumor), N (absence or presence and extent of regional lymph node metastasis) and M (absence or presence of distant metastasis) are three components to describe the anatomical tumor extent. TNM stage is important in treatment decision-making and outcome predicting. The existing oropharyngeal Cancer (OPC) TNM stages have not made distinction of the two sub sites of Human papillomavirus positive (HPV+) and Human papillomavirus negative (HPV-) diseases. We developed novel criteria to assess performance of the TNM stage grouping schemes based on parametric modeling adjusting on important clinical factors. These criteria evaluate the TNM stage grouping scheme in five different measures: hazard consistency, hazard discrimination, explained variation, likelihood difference, and balance. The methods are described in Xu, W., et al. (2015) &amp;lt;&lt;a href=&quot;https://www.austinpublishinggroup.com/biometrics/fulltext/biometrics-v2-id1014.php&quot;&gt;https://www.austinpublishinggroup.com/biometrics/fulltext/biometrics-v2-id1014.php&lt;/a&gt;&amp;gt;." />
<meta name="og:image" content="https://CRAN.R-project.org/CRANlogo.png" />
<meta name="og:type" content="website" />
<meta name="og:url" content="https://CRAN.R-project.org/package=remss" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:site" content="@_R_Foundation" />
<style type="text/css">
  table td { vertical-align: top; }
</style>
</head>
<body>
<h2>remss: Refining Evaluation Methodology on Stage System</h2>
<p>T (extent of the primary tumor), N (absence or presence and extent of regional lymph node metastasis) and M (absence or presence of distant metastasis) are three components to describe the anatomical tumor extent. TNM stage is important in treatment decision-making and outcome predicting. The existing oropharyngeal Cancer (OPC) TNM stages have not made distinction of the two sub sites of Human papillomavirus positive (HPV+) and Human papillomavirus negative (HPV-) diseases. We developed novel criteria to assess performance of the TNM stage grouping schemes based on parametric modeling adjusting on important clinical factors. These criteria evaluate the TNM stage grouping scheme in five different measures: hazard consistency, hazard discrimination, explained variation, likelihood difference, and balance. The methods are described in Xu, W., et al. (2015) &lt;<a href="https://www.austinpublishinggroup.com/biometrics/fulltext/biometrics-v2-id1014.php">https://www.austinpublishinggroup.com/biometrics/fulltext/biometrics-v2-id1014.php</a>&gt;.</p>
<table summary="Package remss summary">
<tr>
<td>Version:</td>
<td>1.0.0</td>
</tr>
<tr>
<td>Depends:</td>
<td>R (&ge; 3.5.0)</td>
</tr>
<tr>
<td>Imports:</td>
<td><a href="../survival/index.html">survival</a></td>
</tr>
<tr>
<td>Suggests:</td>
<td><a href="../knitr/index.html">knitr</a>, <a href="../rmarkdown/index.html">rmarkdown</a>, <a href="../testthat/index.html">testthat</a></td>
</tr>
<tr>
<td>Published:</td>
<td>2019-11-20</td>
</tr>
<tr>
<td>Author:</td>
<td>Wei Xu [aut],
  Susie Su [aut],
  Yi Zhu [cre]</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Yi Zhu  &#x3c;&#x79;&#x69;&#x7a;&#x68;&#x75;&#x38;&#x37;&#x20;&#x61;&#x74;&#x20;&#x67;&#x6d;&#x61;&#x69;&#x6c;&#x2e;&#x63;&#x6f;&#x6d;&#x3e;</td>
</tr>
<tr>
<td>License:</td>
<td><a href="../../licenses/GPL-2">GPL-2</a></td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Materials:</td>
<td><a href="readme/README.html">README</a> </td>
</tr>
<tr>
<td>CRAN&nbsp;checks:</td>
<td><a href="../../checks/check_results_remss.html">remss results</a></td>
</tr>
</table>
<h4>Downloads:</h4>
<table summary="Package remss downloads">
<tr>
<td> Reference&nbsp;manual: </td>
<td> <a href="remss.pdf"> remss.pdf </a> </td>
</tr>
<tr>
<td>Vignettes:</td>
<td>
<a href="vignettes/remss.html">An Introduction to remss</a><br/>
</td>
</tr>
<tr>
<td> Package&nbsp;source: </td>
<td> <a href="../../../src/contrib/remss_1.0.0.tar.gz"> remss_1.0.0.tar.gz </a> </td>
</tr>
<tr>
<td> Windows&nbsp;binaries: </td>
<td> r-devel: <a href="../../../bin/windows/contrib/4.1/remss_1.0.0.zip">remss_1.0.0.zip</a>, r-release: <a href="../../../bin/windows/contrib/4.0/remss_1.0.0.zip">remss_1.0.0.zip</a>, r-oldrel: <a href="../../../bin/windows/contrib/3.6/remss_1.0.0.zip">remss_1.0.0.zip</a> </td>
</tr>
<tr>
<td> macOS&nbsp;binaries: </td>
<td> r-release: <a href="../../../bin/macosx/contrib/4.0/remss_1.0.0.tgz">remss_1.0.0.tgz</a>, r-oldrel: <a href="../../../bin/macosx/el-capitan/contrib/3.6/remss_1.0.0.tgz">remss_1.0.0.tgz</a> </td>
</tr>
</table>
<h4>Linking:</h4>
<p>Please use the canonical form
<a href="https://CRAN.R-project.org/package=remss"><samp>https://CRAN.R-project.org/package=remss</samp></a>
to link to this page.</p>
</body>
</html>
